FTC sues key pharmacy reward supervisors in excess of insulin selling prices The agency introduced motion against Caremark, Convey Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the listing cost of life-saving insulin medication. Pay attention to the short article 10 min This audio is https://jeffreyulcri.theblogfairy.com/30106543/healthcare-news-options